Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$24.65 - $29.0 $180,733 - $212,628
-7,332 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$27.74 - $34.09 $9,875 - $12,136
-356 Reduced 4.63%
7,332 $208,000
Q2 2021

Jul 15, 2021

SELL
$28.76 - $35.98 $10,612 - $13,276
-369 Reduced 4.58%
7,688 $266,000
Q1 2021

Apr 05, 2021

SELL
$27.85 - $34.49 $96,054 - $118,956
-3,449 Reduced 29.98%
8,057 $237,000
Q4 2020

Jan 12, 2021

SELL
$27.53 - $33.79 $25,960 - $31,863
-943 Reduced 7.57%
11,506 $352,000
Q3 2020

Dec 03, 2020

SELL
$21.1 - $29.13 $79,314 - $109,499
-3,759 Reduced 23.19%
12,449 $347,000
Q2 2020

Jul 09, 2020

SELL
$18.94 - $24.93 $6,477 - $8,526
-342 Reduced 2.07%
16,208 $347,000
Q1 2020

Apr 13, 2020

SELL
$16.68 - $32.25 $3,069 - $5,934
-184 Reduced 1.1%
16,550 $370,000
Q4 2019

Jan 29, 2020

SELL
$25.29 - $29.45 $6,398 - $7,450
-253 Reduced 1.49%
16,734 $492,000
Q3 2019

Nov 04, 2019

SELL
$25.62 - $34.96 $11,400 - $15,557
-445 Reduced 2.55%
16,987 $451,000
Q2 2019

Aug 01, 2019

SELL
$31.11 - $34.79 $31,981 - $35,764
-1,028 Reduced 5.57%
17,432 $589,000
Q1 2019

Apr 29, 2019

BUY
$29.0 - $32.83 $535,340 - $606,041
18,460 New
18,460 $592,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.62B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Jacobs & CO Portfolio

Follow Jacobs & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.